August 20, 2018
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

Notice of Recent CTEP-AERS Changes: 
The  CTEP-AERS homepage has been updated and there is now an option to login using your CTEP IAM credentials to submit AERS reports. Read more
The NRG Oncology publications page on the website has moved. Read more

AMENDMENTS
GENITOURINARY
NRG-GU006: Amendment 1, version date: June 14, 2018; and Amendment 2, version date: July 20, 2018 (posted to CTSU).  Please contact the CTSU Help Desk for tracked protocol documents.

RTOG 1115: Amendment 3 has been approved by Health Canada. Sites in Canada can access the NOL and TPD forms on the CTSU website.

GYNECOLOGIC
GOG-0239: Action Letter and Amendment 12 in response to RRA; version date: July 13, 2018 (posted on NRG Oncology).

NRG-GY005: Action Letter and Amendment 5 in response to RRA; version date: July 13, 2018 (posted on CTSU). Please contact the CTSU Help Desk for tracked versions of documents.

OTHER PROTOCOL NOTICES
1. BREAST
NSABP B-55/ BIG 6-13: Memo regarding a WebEx to be held on August 30, 2018 (posted to CTSU)

2. Children’s Oncology Group Protocol AGCT1531: “A Phase III Trial of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors” is open to patient entry. It is available on the CTSU menu with Dr. Allan Covens as NRG Champion. Please enroll your eligible patients to this important trial. 

Enrollment credited to NRG Oncology will count towards membership requirements.


3. VTOC TRAINING
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for September 12, 2018.

 

DRUG SAFETY UPDATES

Safety updates have been issued for the following studies:

DRUG NAME  

PROTOCOL     

WEBSITE FOR SAFETY REPORTS

 Atezolizumab

 NRG-GI004
 NRG-GY009
 CTSU
 CTSU
 Bevacizumab  NSABP B-40  CTSU
 Cabozantinib  NRG-GY001  CTSU
 Ipilimumab  NRG-BN002
 NRG-GY003
 NRG
 NRG
 Nivolumab  NRG-BN002
 NRG-GY002
 NRG-GY003
 NRG
 NRG
 NRG
 Olaparib  NSABP B-55  NRG
 

NOTICE OF RECENT CTEP-AERS CHANGES:

The CTEP-AERS homepage has been updated and there is now an option to login using your CTEP IAM credentials to submit AERS reports. Although optional, we encourage logging in with CTEP IAM username/password because it will provide more functionality and time savings (Reporter and submitter sections automatically populated, Investigator contact information available via drop down menu, new dashboard). The ‘My Submissions’ Dashboard will be a new feature for site users as well. When logged in, users will automatically be taken to this page where they will be able to see all reports they have in progress, submitted, or withdrawn. The ‘My Submissions’ Dashboard is accessed by clicking the ‘Adverse Events’ link at the top of the page once a user has logged in. A note about the ‘My Submissions’ Dashboard: this dashboard will be blank for everyone until people start submitting reports while logged in and will not reflect any reports submitted prior to July 21, 2018. CTEP-AERS login was not available prior to that date and thus old reports are not associated with a user’s IAM account. Additionally, if someone uses the ‘Continue as Guest’ option, the report will not show up on the ‘My Submissions’ Dashboard.

NEW LOCATION ON WEBSITE
Please note that the NRG Oncology Publications tab on the website has relocated. You can now find the publications section under the Clinical Trials tab of the website:  nrgoncology.org/Clinical-Trials/Publications 


PUBLICATIONS REMINDERS

Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

ASCO Research Community Forum Annual Meeting; Sep 23-24, 2018; Washington, DC

American Society for Radiation Oncology (ASTRO); Oct 21-24, 2018; San Antonio, TX

College of American Pathologists (CAP); Oct 20-24, 2018, Chicago, IL

European Society for Medical Oncology (ESMO); Oct 19-23, 2018; Munich, Germany

International Gynecologic Cancer Society (IGCS); Biennial; Sep 14-16, 2018; Kyoto, Japan

PA Breast Cancer Coalition (PBCC); October 19, 2018; Harrisburg, PA

Society of Clinical Research (SOCRA); Sep 28-30, 2018; New Orleans, LA



Upcoming Abstract Submission Deadlines

American Society of Clinical Oncology (ASCO) GI; Jan 17-19, 2019; San Francisco, CA; due to publications committee Sep 12, 2018; meeting abstracts submission deadline Sep 26, 2018

American Society of Clinical Oncology (ASCO) GU; Feb 14-16, 2019; San Francisco, CA; due to publications committee Oct 9, 2018; meeting abstracts submission deadline Oct 23, 2018

European Society for Medical Oncology (ESMO); Oct 19-23, 2018;Munich, Germany; Late-breaking Sep 17, 2018

European Society for Radiotherapy and Oncology (ESTRO); Apr 26-30, 2019; Milan, Italy; due to publications committee Oct 8, 2018; meeting abstracts submission deadline Oct 22, 2018

NRG Oncology is proud to be an active participant of #CancerMoonShot.
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse